Omega-3s reduce the risk of breast cancer in obese women.

According to a study by Professor Andrea Manni and colleagues, supplementing with omega-3 fatty acids may help reduce the risk of breast cancer in obese postmenopausal women.

A study by Professor Andrea Manni at the Pennsylvania Academy of Medicine (USA) and her colleagues, recently published in the journal Cancer Prevention Research, suggests that supplementing with omega-3 fatty acids may help reduce the risk of breast cancer in obese postmenopausal women.

The research team tested 266 postmenopausal women with high breast tissue density, including those with normal weight, overweight, and obese body weights. The aim of the study was to measure changes in breast tissue density over a two-year period.

The study suggests that omega-3 fatty acids may reduce the risk of breast cancer in obese postmenopausal women.

Participants were divided into five different treatment groups: two groups received the anti-estrogen drug Raloxifene at doses of 60 mg/day and 30 mg/day, one group received the omega-3 supplement Lovaza at 4 mg/day, one group received 30 mg Raloxifene in combination with 4 mg Lovaza, and the remaining group was a control group that received no treatment.

After two years, the research team found a link between blood levels of omega-3 fatty acids and a reduction in breast tissue density, but only in obese women.

According to the U.S. National Cancer Institute, women with high breast tissue density have a 4 to 6 times higher risk of developing breast cancer compared to women with low breast tissue density.

Dr. Manni explained: "Omega-3 fatty acids have anti-inflammatory effects, and that's one of the reasons we suspect they may be particularly effective for obese women."

According to VOV